Can Ivabradine Attenuate Post-revascularisation Microcirculatory Dysfunction in Flow Limiting Coronary Artery Disease?
Phase of Trial: Phase IV
Latest Information Update: 31 May 2016
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris; Coronary artery disease
- Focus Pharmacodynamics
- Acronyms MICRO-PCI
- 10 Jun 2017 Biomarkers information updated
- 20 May 2016 Planned number of patients changed from 64 to 75.
- 20 May 2016 Status changed from withdrawn prior to enrolment to suspended.